Bragger v. Trinity Capital Enterprise Corp., 943
| Decision Date | 15 July 1994 |
| Docket Number | No. 943,D,943 |
| Citation | 30 F.3d 14 |
| Parties | Fed. Sec. L. Rep. P 98,322 Barry L. BRAGGER, Plaintiff-Appellee, v. TRINITY CAPITAL ENTERPRISE CORPORATION; Lawrence Burstein; Barry Goldin; GKN Securities Corp., Defendants-Appellees, Ivax Corporation; Diamedix Corporation; Joseph L. Giegel, Defendants-Appellants. ocket 93-7825. |
| Court | U.S. Court of Appeals — Second Circuit |
Laurence D. Paskowitz, New York City (Lester L. Levy, Wolf Popper Ross Wolf & Jones, of counsel), for plaintiff-appellee Barry L. Bragger.
Martin Stein, New York City (Parker Duryee Rosoff & Haft, of counsel), for defendants-appellees Trinity Capital Enterprise Corp., Lawrence Burstein and Barry Goldin.
Nancy R. Sills, New York City (Steven Mallis, Graubard Mollen Horowitz Pomeranz & Shapiro, New York City, of counsel), for defendant-appellee GKN Securities Corp.
Before: OAKES, KEARSE and CARDAMONE, Circuit Judges.
This appeal is from a final judgment entered July 28, 1993 pursuant to Fed.R.Civ.P. 54(b), by the United States District Court for the Southern District of New York (McKenna, J.) approving a settlement in a class action securities fraud suit. While this appeal was pending, the issue on appeal from the district court has become moot. When a judgment becomes moot it is like hanging a doubt on it. For that reason, an appellate court is generally charged with ordering that the judgment, to the extent that those portions appealed from have become moot, be vacated and the appeal be dismissed. Such is what we do here.
The present appellants, defendants in the court below, are Ivax Corporation (Ivax), Diamedix Corporation (Diamedix), and Joseph L. Giegel. Ivax is a holding company. Its subsidiaries are involved in specialty chemicals, pharmaceuticals, and medical diagnostics. Diamedix, one of those subsidiaries, manufactures medical diagnostic kits that are sold to medical laboratories. Joseph L. Giegel is the president of Diamedix. GDU Trading (GDU) is a distributor of Diamedix diagnostic kits.
The present appellees, who were also defendants in the district court, are Trinity Capital Enterprise Corporation (Trinity), a capital investment firm that raises funds by public offerings and searches for businesses to acquire by purchase or merger; Barry Goldin and Lawrence Burstein, Trinity's principals, serving as its chairman and president respectively; and GKN Securities Corporation (GKN), which acted as underwriter of the public offering at issue in this litigation. On September 12, 1991 Trinity raised $7.85 million by a public offering.
From October 1991 through January 1992 Trinity evaluated more than a dozen businesses as candidates for a possible merger. Among the prospects were Diamedix and GDU. On February 5, 1992 Trinity and Ivax signed a letter of intent which stated that Trinity would merge with Diamedix and acquire GDU. Trinity and Ivax then issued a joint press release describing the basic terms of the proposed merger and giving general background information about the various corporations involved.
Another appellee, Barry L. Bragger, was the plaintiff in the trial court. He purchased 50 shares of Trinity stock for about $500 on March 5, 1992. On April 23, 1992 Trinity, Ivax, Diamedix and GDU executed a formal merger agreement. Trinity thereafter filed a Form S-4 prospectus and proxy statement on July 10, 1992 with the Securities and Exchange Commission.
Four months later, on November 19, 1992, the merger agreement was terminated by mutual agreement of the parties. The termination occurred for two reasons: Diamedix's failure to disclose that it was being investigated by the Food and Drug Administration (FDA) for failure to obtain that agency's approval before making certain changes in the package inserts accompanying six of its diagnostic kits and failing to notify its customers of the changes; and Ivax's failure to disclose that it had lent money to GDU to finance its inventories because a substantial portion of GDU's accounts receivable were more than a year old.
On March 25, 1992 Bragger filed a class action securities fraud suit against Trinity, its officers Burstein and Goldin, and the underwriter GKN (referred to hereafter collectively as the Trinity defendants), alleging violations of Sec. 10(b) of the Securities and Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and Sec. 20(a) of the Securities and Exchange Act of 1934. Plaintiff's complaint alleged a failure by Trinity to disclose material information--primarily concerning the FDA's investigation of Diamedix. A year later, on April 1, 1993, Bragger and the Trinity defendants filed a settlement agreement disposing of all the claims between them. The next day, Bragger amended his complaint to add as defendants Ivax, Diamedix and Giegel (referred to hereafter collectively as the Ivax defendants).
On June 30 and July 16, 1993 the district court held evidentiary hearings on the proposed partial settlement, which included a bar order prohibiting the Ivax defendants from bringing any contribution or indemnification claims against the settling Trinity defendants. In a memorandum and order entered July 27, 1993 approving the settlement, it made findings of fact and set forth conclusions of law. The trial court not only determined that the proposed bar order was appropriate, but that any subsequent judgment recovered against the Ivax defendants must be reduced by the pro tanto method. Judgment approving the settlement was entered on July 28, 1993. The Ivax defendants appealed, challenging the constitutionality of the bar order and contending that reduction of any judgment against them should be reduced by the proportional rather than by the pro tanto method. We heard oral argument in this appeal on February 4, 1994.
Meanwhile, the district court--exercising its jurisdiction over those aspects of the case not on appeal, see New York State NOW v. Terry, 886 F.2d 1339, 1349-50 (2d Cir.1989), cert. denied, 495 U.S. 947, 110 S.Ct. 2206, 109 L.Ed.2d 532 (1990)--ruled on the Ivax defendants' motion to dismiss plaintiff's class action complaint against it for failure to state a claim upon which relief may be granted pursuant to Fed.R.Civ.P. 12(b)(6). These defendants had moved for dismissal of plaintiff's complaint in lieu of filing an answer. Judge McKenna granted the motion and dismissed plaintiff's complaint in its entirety in an order dated March 7, 1994. Final judgment was entered on March 16, 1994. Plaintiff Bragger did not appeal from the dismissal of his suit against the Ivax defendants. Thus, since the settlement between the plaintiff Bragger and the Trinity defendants still stands, all that is presently before us is the Ivax defendants' appeal from the July 28, 1993 judgment approving the settlement.
Because of the dismissal of plaintiff's complaint against the Ivax defendants, plaintiff recommended to us in a letter dated April 13, 1994 that the pending appeal be dismissed as moot. A letter response dated May 2, 1994 from the Ivax defendants, after an inquiry from the Court, basically agreed that the case is moot. The Ivax defendants also suggested that we vacate such part of the district court's rulings as were the subject of its appeal.
Article III, section 2 of the Constitution limits the jurisdiction of the federal courts to concrete cases and controversies. Because of this limit, federal courts "are without power to decide questions that cannot affect the rights of litigants in the case before them." North Carolina v. Rice, 404 U.S. 244, 246, ...
To continue reading
Request your trial
-
In re Crazy Eddie Securities Litigation
...Inc. v. AmClyde, 511 U.S. 202, 209-10, 114 S.Ct. 1461, 1466, 128 L.Ed.2d 148 (1994), an admiralty case. See Bragger v. Trinity Capital Enterprise Corp., 30 F.3d 14, 17 (2d Cir.1994) (vacating order that judgment in securities fraud case be reduced on a pro tanto basis in light of McDermott)......
-
Banks ex rel. Banks v. Yokemick
...sprouting in other areas of federal law. Most notable is the Second Circuit's reference to McDermott in Bragger v. Trinity Capital Enterp. Corp., 30 F.3d 14 (2d Cir. 1994). In the securities fraud dispute there at issue, the Circuit Court, while sustaining dismissal of the underlying action......
-
Hassoun v. Searls
...and remand with a direction to dismiss.’ " Arizonans for Off. English , 520 U.S. at 71, 117 S.Ct. 1055 ; see Bragger v. Trinity Cap. Enter. Corp. , 30 F.3d 14, 17 (2d Cir. 1994). "The reason for this is ... to avoid giving preclusive effect to a judgment never reviewed by an appellate court......
-
Fox v. Board of Trustees of State University of New York
...are without power to decide questions that cannot affect the rights of litigants in the case before them"); Bragger v. Trinity Capital Enter. Corp., 30 F.3d 14, 16 (2d Cir.1994) (same). The required legally cognizable interest has alternatively been described as a requirement that a plainti......
-
Giving Credit Where Credit Is Due: Applying the Proper Set-Off Rules in FELA and Jones Act Cases After AmClyde, Ayers, and Schadel
...n.14. 7. RESTATEMENT (THIRD) OF TORTS: APPORTIONMENT OF LIABILITY § 16 cmt. c (2000); see, e.g. , Bragger v. Trinity Capital Enterp. Corp., 30 F.3d 14, 17 (2d Cir. 1994) (securities litigation); Banks ex rel. Banks v. Yokemick, 177 F. Supp. 2d 239 (S.D.N.Y. 2001) (§ 1983 of the Civil Rights......